Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up  |  Already a member? Sign In  |  Visit IQPC.com  
Pharma IQ

Pre-Clinical (Discovery and Development)

Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.

Articles

"Not Even Wrong" – The Failure of Drug-likeness Rules

Contributor: Jonas Boström
Posted: 3/20/2013

"Not Even Wrong" – The Failure of Drug-likeness Rules - Jonas Boström

Jonas Boström, of AstraZeneca explains how the idea of drug-likeness rules has been controversial ever since Lipinski introduced his rule of five for predicting oral bioavailability 15 years ago. Full Article »

Events related to this topic:
More Articles
Videos

President of ISBER: Looking to the Future of Biospecimen Science

Contributor: Kathi Shea
Posted: 4/11/2013

President of ISBER: Looking to the Future of Biospecimen Science - Kathi Shea

Kathi Shea, President at ISBER 2012-2013, discusses the goals for ISBER in 2013 Full Video »

Events related to this topic:
More Videos
Podcasts

Lundbeck's Ludovic Otterbein on Bottlenecks and Best Practices in Compound Management

Contributor: Andrea Charles
Posted: 3/13/2013

Lundbeck's Ludovic Otterbein on Bottlenecks and Best Practices in Compound Management - Andrea Charles

"Every company has compound collections of different sizes, but we all face the same challenge of the rising cost of R&D," said Ludovic Otterbein, Head of Global Compound Management and Analytical Chemistry at at H. Lundbeck A/S. Full Podcast »

Events related to this topic:
More Podcasts
Columns

Copy More! Copy Better!

Contributor: Jonas Boström
Posted: 5/7/2013

Copy More! Copy Better! - Jonas Boström

In his latest column, Jonas explains the pharma industry should re-examine its aversion to copying and how this aversion can restrict innovation. He then makes the case that 'follow-on' drugs are good for companies and patients. Full Column »

Events related to this topic:
More Columns
Whitepapers

A Global Guide to Formulation and Drug Delivery

Posted: 3/19/2013

A Global Guide to Formulation and Drug Delivery

Advancing innovation in drug delivery and facilitating best practice in formulation. Produced in association with Pharma IQ’s 3rd Annual Global Formulation and Drug Delivery Summit Full Whitepaper »
Events related to this topic:
More Whitepapers

About Pre-Clinical (Discovery and Development)

This portal provides executives working within pre-clinical research, with the latest developments in compound management, discovery partnerships and formulation to enhance the lead optimisation and speed up candidate development.

Advertisement

Events of Interest
Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.

what is the retention time of remnanth samples as per Drug and Cosmetics act.

Posted by:  Nimesh | Answer this question

what does vally mean in studying the plasma conc graph?

Posted by:  talieha | Answer this question

QA or RA which one best

Posted by:  rikin_suzlon65 | Answer this question

Is it possible with a MEG (Magnetoencephalography) to measure the neural activitu or the VLPO (neuron firings)?

Posted by:  Insomnia | Answer this question

what is the requirement of chewable tablet bioequivalance study for brazil and what are the general

Posted by:  ramesh89pharma | Answer this question

what is mean by partical size distribution

Posted by:  balasaheb jadhav | Answer this question

what is the use of Proluton Depot for pregnant women?

Posted by:  etc.com | Answer this question

QA or RA which one best

Posted by:  rikin_suzlon65 | Answer this question

WHAT IS PH?

Posted by:  A.Veerendra nath reddy | Answer this question